TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
RXST

Rxsight Inc

Healthcare · Medical Devices

4.80$ +1.7% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Rxsight Inc (RXST) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 353 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RXST
Line item Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– – – 101 96 95 204 193 177 167 156 150 203 195 182 183 183 305 310 319 313 309 309 312 304 353
– – – 82 78 76 186 176 161 150 139 135 188 180 168 168 169 281 287 294 288 284 284 287 279 327
– – – 14 24 42 68 24 24 24 8.9 12 11 8.8 9.9 9.7 33 24 17 17 28 40 30 20 18 13
– – – 69 64 62 168 159 144 129 113 106 154 147 132 127 125 233 237 237 229 227 228 228 218 209
– – – 2.9 2.3 3.9 4.4 4.9 5.6 6.9 9.0 11 13 13 15 20 22 26 25 30 31 28 24 23 22 79
– – – 8.3 9.8 8.5 9.4 8.0 8.5 12 15 15 18 18 19 17 19 19 22 22 24 25 29 32 35 37
– – – – 18 13 12 11 11 16 11 10 9.8 14 – – – – – – – – – – – –
– – – 398 398 408 53 54 54 57 60 60 58 38 20 22 19 30 33 37 34 31 33 36 37 89
– – – 12 6.9 11 9.2 11 11 13 16 17 15 17 19 21 18 20 23 26 23 20 22 26 27 80
– – – 1.3 1.3 1.4 1.5 1.5 1.7 1.8 1.9 2.0 2.0 2.0 2.0 1.8 1.6 0.7 0.7 1.0 1.1 1.1 1.3 1.2 1.5 1.7
– – – 1.1 1.9 2.3 1.7 1.7 2.6 3.3 4.2 2.6 3.7 4.0 4.1 3.9 5.1 5.1 4.6 4.5 7.1 3.3 3.4 5.3 7.1 6.3
– – – 24 29 44 44 43 43 40 43 40 43 20 – – – – – – – – – – – –
– – – -298 -302 -313 151 138 123 110 96 90 145 157 161 160 164 275 277 281 279 278 276 276 267 263
– – – -431 -437 -451 -464 -479 -497 -514 -530 -546 -559 -573 -585 -595 -604 -610 -616 -622 -630 -642 -652 -661 -677 -689
19 19 19 19 19 26 19 27 27 28 28 28 32 34 36 36 37 38 40 40 41 41 41 41 41 41

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?